Marsh & McLennan Companies, Inc. vs Sana Biotechnology Inc — how do they compare? Marsh & McLennan Companies, Inc. trades at $180.6 (market cap $87.77B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 100.4× Sana Biotechnology Inc's market cap, and Marsh & McLennan Companies, Inc. pays a 2.17% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| MRSH | SANA | |
|---|---|---|
Market Cap | $87.77B | $873.84M |
Sector | Financials | Health |
52-Week High | $211.21 | $5.92 |
52-Week Low | $157.32 | $2.68 |
Enterprise Value | $108.61B | $848.03M |
Dividend Yield | 2.17% | — |
Trailing returns across standard periods
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →